Lista de obras -

Anti-PD-1/PD-L1-induced psoriasis from an oncological perspective.

artículo científico publicado en 2017

Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non-Small Cell Lung Carcinoma: the ROSING Study

artículo científico publicado en 2019

Comprehensive cross-platform comparison of methods for non-invasive EGFR mutation testing: Results of the RING observational trial

artículo científico publicado en 2020

Concurrent chemoradiation for locally advanced stage III non-small cell lung cancer with cisplatin, vinorelbine, and thoracic radiotherapy: a phase II study from the Galician Lung Cancer Group

artículo científico publicado en 2018

Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients

scientific article published on 24 February 2020

Development of de novo psoriasis during nivolumab therapy for metastatic renal cell carcinoma: immunohistochemical analyses and clinical outcome.

artículo científico publicado en 2017

Development of psoriatic arthritis during nivolumab therapy for metastatic non-small cell lung cancer, clinical outcome analysis and review of the literature.

artículo científico

Evaluation of the lung immune prognostic index in advanced non-small cell lung cancer patients under nivolumab monotherapy

artículo científico publicado en 2019

Long-term Response to Nivolumab and Acute Renal Failure in a Patient with Metastatic Papillary Renal Cell Carcinoma and a PD-L1 Tumor Expression Increased with Sunitinib Therapy: A Case Report

artículo científico publicado en 2016

Lung Cancer and Liquid Biopsy: Realities and Challenges in Routine Clinical Practice

scientific article published on 11 January 2019

PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-Analysis

artículo científico publicado en 2020

Paclitaxel and cisplatin in the treatment of metastatic non-small-cell lung cancer during pregnancy

scientific article published on 01 June 2008

Re: Francesco Piva, Matteo Santoni, Marina Scarpelli, et al's Letter to the Editor re: Daniel M. Geynisman. Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with